Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
Callio Therapeutics
Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026
May 27, 2026
Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026
April 15, 2026